Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CTEC: Cholestech any other investors? -- Ignore unavailable to you. Want to Upgrade?

To: epicure who wrote (368)	12/16/1997 5:05:00 PM
From: MulhollandDrive	Read Replies (1) \| Respond to of 710

alexa, when are earnings due? thanks, bp

To: epicure who wrote (368)	12/17/1997 11:18:00 PM
From: Duane L. Olson	Read Replies (1) \| Respond to of 710

Alexa, Perhaps I missed earlier posts RE: R&D. Are any of the following "in the pipeline" to your knowledge? "The Company is currently developing additional tests to detect and monitor disease states such as metabolic bone diseases and disorders, liver function, prostate cancer, cardiovascular disease and diabetes. Each of these new tests is at an early stage of development and the Company will be required to undertake time-consuming and costly development activities and seek regulatory approval for these new tests before such tests can be marketed. However, the Company believes that its future revenue growth and profitability will depend, in part, upon its ability to complete development and successfully introduce new test panels designed to extend the Cholestech L.D.X System's capabilities to include additional tests useful in the diagnostic screening and therapeutic monitoring markets. The Company currently anticipates that research and development expenditures will increase in future periods as product development and manufacturing scale-up efforts for new tests increase. dki